FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...
AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...
In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
Health data show that COVID-19 still surpasses all other infectious respiratory illnesses as a cause of severe illness, ...
The FDA has approved FluMist nasal spray as the first at-home flu vaccine. People aged 18 and older can now self-administer ...
In a first, the Food and Drug Administration on Friday approved AstraZeneca's FluMist, a nasal spray flu vaccine that anyone ...
People ages 6 months and older should receive a vaccine every year. It is also recommended that people over 65 years old get ...
According to health experts, getting the flu vaccine can help reduce hospitalizations and death. A 2023 CDC study showed that ...
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
See your plan by selecting location, age, and other applicable factors Sign up to be alerted when there are vaccination updates in your state: The Plan Your Vaccine page will be updated as new ...